Internal Medicine

Heart Failure

The Failing Pump

Cardiovascular Disease

Now we're moving to heart failure, a clinical syndrome where the heart can't pump enough blood to meet the body's metabolic demands. Think of it as a pump that's become inefficient - it might still be working, but not effectively enough. I'll guide you through the types, pathophysiology, compensatory mechanisms, clinical presentation, and management of this common condition that affects millions worldwide. Understanding heart failure is crucial as it's often the end stage of many cardiovascular diseases. Let's explore this important topic!

🩺 Definition and Classification

Heart failure is a complex clinical syndrome resulting from any structural or functional impairment of ventricular filling or ejection of blood. It's classified in several ways to help guide diagnosis and treatment.

By Ejection Fraction

  • HFrEF: Heart Failure with reduced EF (<40%)
  • HFmrEF: HF with mildly reduced EF (41-49%)
  • HFpEF: HF with preserved EF (>50%)

By Cardiac Output

  • Low-output HF: Reduced cardiac output
  • High-output HF: Increased demands exceed capacity
NYHA Class Description Symptoms
Class I No limitation No symptoms with ordinary activity
Class II Slight limitation Comfortable at rest, symptoms with ordinary activity
Class III Marked limitation Comfortable at rest, symptoms with less than ordinary activity
Class IV Severe limitation Symptoms at rest, unable to carry out any physical activity
Clinical Pearl: Remember that HFpEF is becoming increasingly common and is often associated with hypertension, older age, female gender, and comorbidities like obesity and diabetes.

🔄 Pathophysiology

The pathophysiology of heart failure involves a complex interplay between initial myocardial injury, compensatory mechanisms, and eventual maladaptation that leads to progressive ventricular dysfunction.

Initial Insults

  • Myocardial infarction
  • Pressure overload (hypertension, AS)
  • Volume overload (valvular regurgitation)
  • Myocardial disease (cardiomyopathy)

Compensatory Mechanisms

  • Frank-Starling mechanism
  • Neurohormonal activation (SNS, RAAS)
  • Myocardial hypertrophy
  • Ventricular remodeling

Maladaptive Changes

  • Progressive ventricular dilation
  • Fibrosis and cell death
  • Beta-receptor downregulation
  • Increased wall stress
Tutor Tip: Think of heart failure pathophysiology as initially helpful compensatory mechanisms that eventually become harmful, creating a vicious cycle of worsening cardiac function.

👨‍⚕️ Clinical Presentation

Heart failure symptoms result from inadequate cardiac output (forward failure) and systemic/pulmonary congestion (backward failure). Recognition of these patterns helps in diagnosis and management.

Common Symptoms

Left Heart Failure

  • Dyspnea (exertional, orthopnea, PND)
  • Fatigue, weakness
  • Reduced exercise tolerance
  • Cough, wheezing (cardiac asthma)
  • Pink, frothy sputum (pulmonary edema)

Right Heart Failure

  • Peripheral edema
  • Abdominal distension (ascites)
  • Hepatomegaly, right upper quadrant pain
  • Anorexia, early satiety
  • Jugular venous distension

Physical Examination Findings

Finding Significance Associated With
S3 gallop Volume overload Systolic HF, dilated ventricles
S4 gallop Stiff ventricle Diastolic HF, hypertension
Rales/crackles Pulmonary congestion Left heart failure
Hepatojugular reflux Elevated RA pressure Right heart failure
Displaced PMI Cardiomegaly Ventricular dilation
Acute Decompensated HF: Sudden worsening of HF symptoms requiring urgent treatment. Characterized by severe dyspnea, hypoxia, and often pulmonary edema. Requires immediate oxygen, diuretics, and vasodilators.

🔍 Diagnosis and Evaluation

Diagnosis of heart failure involves a combination of clinical assessment, biomarkers, and imaging studies to confirm the diagnosis, determine etiology, and assess severity.

Diagnostic Approach

Test Purpose Key Findings
BNP/NT-proBNP Diagnosis, prognosis Elevated in HF (BNP >100 pg/mL)
Echocardiogram Assess structure/function EF, chamber size, wall motion, valves
ECG Identify etiology Prior MI, arrhythmias, LVH
Chest X-ray Assess congestion Cardiomegaly, pulmonary edema
Blood tests Identify triggers Electrolytes, renal function, thyroid
Important: Always try to identify the underlying cause of heart failure (ischemic, valvular, hypertensive, etc.) as this guides specific treatment approaches.

💊 Management

Management of heart failure aims to relieve symptoms, improve quality of life, prevent hospitalizations, and reduce mortality. Treatment differs between HFrEF and HFpEF.

Lifestyle Modifications

Diet and Activity

  • Sodium restriction (<2-3 g/day)
  • Fluid restriction in severe cases
  • Regular, moderate physical activity
  • Weight monitoring daily

Other Measures

  • Smoking cessation
  • Alcohol limitation/avoidance
  • Vaccinations (influenza, pneumococcal)
  • Sleep apnea treatment if present

Pharmacological Therapy for HFrEF

Drug Class Examples Mechanism Key Benefits
ACE Inhibitors/ARB/ARNI Lisinopril, Valsartan, Sacubitril/Valsartan Block RAAS, reduce afterload Mortality benefit, symptom improvement
Beta Blockers Bisoprolol, Carvedilol, Metoprolol Reduce heart rate, block SNS Mortality benefit, reverse remodeling
MRAs Spironolactone, Eplerenone Block aldosterone effects Mortality benefit, reduce fibrosis
SGLT2 Inhibitors Empagliflozin, Dapagliflozin Multiple mechanisms Mortality/hospitalization benefit
Diuretics Furosemide, Bumetanide Reduce fluid overload Symptom relief, no mortality benefit
Treatment Goal: For HFrEF, aim for "quadruple therapy" with ACEi/ARNI, beta-blocker, MRA, and SGLT2 inhibitor to maximize mortality benefit.

⚠️ Advanced Therapies and Devices

For patients with advanced heart failure despite optimal medical therapy, device-based treatments and surgical options may be considered.

Device Therapy

  • ICD: Prevents sudden cardiac death
  • CRT: Improves synchrony in LBBB
  • LVAD: Mechanical circulatory support

Surgical Options

  • Heart transplantation: Definitive treatment
  • Valve surgery: For valvular causes
  • CABG: For ischemic cardiomyopathy
Clinical Insight: Referral to a heart failure specialist should be considered for all patients with persistent symptoms despite optimal medical therapy or those with recurrent hospitalizations.

🧠 Key Takeaways

  • Heart failure is a clinical syndrome, not a specific disease
  • Classify by ejection fraction: HFrEF, HFmrEF, HFpEF
  • Pathophysiology involves initial injury, compensation, then maladaptation
  • Symptoms reflect low cardiac output and systemic/pulmonary congestion
  • Diagnosis requires clinical assessment, biomarkers, and imaging
  • HFrEF has proven mortality-reducing medications (ACEi/ARNI, beta-blockers, MRAs, SGLT2i)
  • HFpEF management focuses on comorbidities and symptom control
  • Advanced therapies include devices and transplantation

🧭 Conclusion

We've explored the comprehensive landscape of heart failure, student—from its pathophysiology to advanced management strategies. Remember that heart failure is a chronic condition requiring lifelong management and patient engagement. I encourage you to understand the differences between HFrEF and HFpEF, as this fundamentally changes treatment approaches. Excellent work! Next, we'll examine ischemic heart disease, a common cause of heart failure.

Heart failure management has evolved dramatically—we now have medications that not only improve symptoms but significantly prolong life.